<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38256558</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Overview of COVID-19 Infection, Treatment, and Prevention in Children.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">424</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13020424</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19), caused by the novel respiratory virus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-was declared a global pandemic by the World Health Organization on 11 March 2020. Since then, substantial gains have been made in our understanding of COVID-19 epidemiology, disease presentation, and management. While children tend to have less severe disease courses compared to adults, children can still develop severe COVID-19 infections, particularly in those with underlying medical conditions such as obesity, chronic lung disease, or prematurity. In addition, children are at risk of severe complications of COVID-19 infection, such as multisystem inflammatory syndrome in children (MIS-C) or long COVID. The case definitions of MIS-C and long COVID have continued to evolve with the increased understanding of these new entities; however, improved methods of diagnosis and determination of the optimal management are still needed. Furthermore, with the continued circulation of SARS-CoV-2 variants, there remains a need for clinicians to remain up-to-date on the latest treatment and prevention options. The purpose of this review is to provide an evidence-based review of what we have learned about COVID-19 in children since the start of the pandemic and how best to counsel children and their families on the best methods of prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Carol M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Infectious Diseases, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>The author declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38256558</ArticleId><ArticleId IdType="pmc">PMC10817068</ArticleId><ArticleId IdType="doi">10.3390/jcm13020424</ArticleId><ArticleId IdType="pii">jcm13020424</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC  COVID Data Tracker.  [(accessed on 13 November 2023)];2023  Available online:  https://covid.cdc.gov/covid-data-tracker.</Citation></Reference><Reference><Citation>Blatz A.M., Randolph A.G. Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents. Crit. Care Clin. 2022;38:571&#x2013;586. doi: 10.1016/j.ccc.2022.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2022.01.005</ArticleId><ArticleId IdType="pmc">PMC8743385</ArticleId><ArticleId IdType="pubmed">35667744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Q., Wu Y., Mei S., Ye C., Zou X., Zhang Z., Liu X., Wei L., Truelove S.A., Zhang T., et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: A retrospective cohort study. Lancet Infect. Dis. 2020;20:911&#x2013;919. doi: 10.1016/S1473-3099(20)30287-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30287-5</ArticleId><ArticleId IdType="pmc">PMC7185944</ArticleId><ArticleId IdType="pubmed">32353347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawood F.S., Porucznik C.A., Veguilla V., Stanford J.B., Duque J., Rolfes M.A., Dixon A., Thind P., Hacker E., Castro M.J.E., et al. Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection among Children and Adults in Utah and New York City, New York. JAMA Pediatr. 2022;176:59&#x2013;67. doi: 10.1001/jamapediatrics.2021.4217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.4217</ArticleId><ArticleId IdType="pmc">PMC8501415</ArticleId><ArticleId IdType="pubmed">34623377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu V.T., Yousaf A.R., Chang K., Schwartz N.G., McDaniel C.J., Lee S.H., Szablewski C.M., Brown M., Drenzek C.L., Dirlikov E., et al. Household Transmission of SARS-CoV-2 from Children and Adolescents. N. Engl. J. Med. 2021;385:954&#x2013;956. doi: 10.1056/NEJMc2031915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031915</ArticleId><ArticleId IdType="pmc">PMC8314736</ArticleId><ArticleId IdType="pubmed">34289272</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul L.A., Daneman N., Schwartz K.L., Science M., Brown K.A., Whelan M., Chan E., Buchan S.A. Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection. JAMA Pediatr. 2021;175:1151&#x2013;1158. doi: 10.1001/jamapediatrics.2021.2770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2770</ArticleId><ArticleId IdType="pmc">PMC8369380</ArticleId><ArticleId IdType="pubmed">34398179</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutzoukas A.E., Zimmerman K.O., Inkelas M., Brookhart M.A., Benjamin D.K., Butteris S., Koval S., DeMuri G.P., Manuel V.G., Smith M.J., et al. School Masking Policies and Secondary SARS-CoV-2 Transmission. Pediatrics. 2022;149:e2022056687. doi: 10.1542/peds.2022-056687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-056687</ArticleId><ArticleId IdType="pmc">PMC9647584</ArticleId><ArticleId IdType="pubmed">35260896</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson P., Worrell M.C., Malone S., Fritz S.A., McLaughlin H.P., Montgomery B.K., Boyle M., Gomel A., Hayes S., Maricque B., et al. Modifications to student quarantine policies in K-12 schools implementing multiple COVID-19 prevention strategies restores in-person education without increasing SARS-CoV-2 transmission risk, January&#x2013;March 2021. PLoS ONE. 2022;17:e0266292. doi: 10.1371/journal.pone.0266292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266292</ArticleId><ArticleId IdType="pmc">PMC9584452</ArticleId><ArticleId IdType="pubmed">36264919</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakkar P.V., Zimmerman K.O., Brookhart M.A., Erickson T.R., Benjamin D.K., Kalu I.C., ABC Science Collaborative COVID-19 Incidence Among Sixth through Twelfth Grade Students by Vaccination Status. Pediatrics. 2022;149:e2022056230. doi: 10.1542/peds.2022-056230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-056230</ArticleId><ArticleId IdType="pmc">PMC9647573</ArticleId><ArticleId IdType="pubmed">35190835</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M.M., Benjamin D.K., Mann T.K., Fist A., Blakemore A., Diaz K.S., Kim H., Edwards L.J., Rak Z., Brookhart M.A., et al. Test-to-Stay After SARS-CoV-2 Exposure: A Mitigation Strategy for Optionally Masked K-12 Schools. Pediatrics. 2022;150:e2022058200. doi: 10.1542/peds.2022-058200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-058200</ArticleId><ArticleId IdType="pmc">PMC9647593</ArticleId><ArticleId IdType="pubmed">35971240</ArticleId></ArticleIdList></Reference><Reference><Citation>Karron R.A., Hetrich M.K., Na Y.B., Knoll M.D., Schappell E., Meece J., Hanson E., Tong S., Lee J.S., Veguilla V., et al. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection among Children Aged 0 to 4 Years and Their Household Members. JAMA Netw. Open. 2022;5:e2227348. doi: 10.1001/jamanetworkopen.2022.27348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.27348</ArticleId><ArticleId IdType="pmc">PMC9434363</ArticleId><ArticleId IdType="pubmed">36044218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M.K., Hanson K.E., Englund J.A., Lee F., Lee M.J., Loeb M., Morgan D.J., Patel R., El Alayli A., El Mikati I.K., et al. The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing. Clin. Infect. Dis. 2023:ciad032. doi: 10.1093/cid/ciad032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad032</ArticleId><ArticleId IdType="pubmed">36702617</ArticleId></ArticleIdList></Reference><Reference><Citation>Inagaki K., Hobbs C.V. COVID-19: A Pediatric Update in Epidemiology, Management, Prevention, and Long-term Effects. Pediatr Rev. 2023;44:243&#x2013;254. doi: 10.1542/pir.2022-005686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.2022-005686</ArticleId><ArticleId IdType="pubmed">37122040</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophers B., Gallo Marin B., Oliva R., Powell W.T., Savage T.J., Michelow I.C. Trends in clinical presentation of children with COVID-19: A systematic review of individual participant data. Pediatr. Res. 2022;91:494&#x2013;501. doi: 10.1038/s41390-020-01161-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-020-01161-3</ArticleId><ArticleId IdType="pmc">PMC7965792</ArticleId><ArticleId IdType="pubmed">32942286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang A., Chorath K., Moreira A., Evans M., Burmeister-Morton F., Burmeister F., Naqvi R., Petershack M., Moreira A. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020;24:100433. doi: 10.1016/j.eclinm.2020.100433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100433</ArticleId><ArticleId IdType="pmc">PMC7318942</ArticleId><ArticleId IdType="pubmed">32766542</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff R.C., Campbell A.P., Taylor C.A., Chai S.J., Kawasaki B., Meek J., Anderson E.J., Weigel A., Monroe M.L., Reeg L., et al. Risk Factors for Severe COVID-19 in Children. Pediatrics. 2022;149:e2021053418. doi: 10.1542/peds.2021-053418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-053418</ArticleId><ArticleId IdType="pmc">PMC9213563</ArticleId><ArticleId IdType="pubmed">34935038</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S., Whittaker C., Semenova E., Rashid T., Parks R.M., Blenkinsop A., Unwin H.J.T., Mishra S., Bhatt S., Gurdasani D., et al. Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US. JAMA Netw. Open. 2023;6:e2253590. doi: 10.1001/jamanetworkopen.2022.53590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.53590</ArticleId><ArticleId IdType="pmc">PMC9887489</ArticleId><ArticleId IdType="pubmed">36716029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobbs C.V., Woodworth K., Young C.C., Jackson A.M., Newhams M.M., Dapul H., Maamari M., Hall M.W., Maddux A.B., Singh A.R., et al. Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants. Pediatr. Infect. Dis. J. 2022;41:e81&#x2013;e86. doi: 10.1097/INF.0000000000003435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003435</ArticleId><ArticleId IdType="pmc">PMC8828316</ArticleId><ArticleId IdType="pubmed">34955519</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith N., Poss&#xe9;m&#xe9; C., Bondet V., Sugrue J., Townsend L., Charbit B., Rouilly V., Saint-Andr&#xe9; V., Dott T., Pozo A.R., et al. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity. Nat. Commun. 2022;13:7254. doi: 10.1038/s41467-022-34895-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34895-1</ArticleId><ArticleId IdType="pmc">PMC9700809</ArticleId><ArticleId IdType="pubmed">36434007</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. SARS-CoV-2 infections in children: Understanding diverse outcomes. Immunity. 2022;55:201&#x2013;209. doi: 10.1016/j.immuni.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8769938</ArticleId><ArticleId IdType="pubmed">35093190</ArticleId></ArticleIdList></Reference><Reference><Citation>Halasa N.B., Spieker A.J., Young C.C., Olson S.M., Newhams M.M., Amarin J.Z., Moffitt K.L., Nakamura M.M., Levy E.R., Soma V.L., et al. Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children. Clin. Infect. Dis. 2023;76:e280&#x2013;e290. doi: 10.1093/cid/ciac477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac477</ArticleId><ArticleId IdType="pmc">PMC9384330</ArticleId><ArticleId IdType="pubmed">35717646</ArticleId></ArticleIdList></Reference><Reference><Citation>Jone P.N., John A., Oster M.E., Allen K., Tremoulet A.H., Saarel E.V., Lambert L.M., Miyamoto S.D., de Ferranti S.D. SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement from the American Heart Association. Circulation. 2022;145:e1037&#x2013;e1052. doi: 10.1161/CIR.0000000000001064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001064</ArticleId><ArticleId IdType="pubmed">35400169</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere K.L., Riggs B.J., Poussaint T.Y., Young C.C., Newhams M.M., Maamari M., Walker T.C., Singh A.R., Dapul H., Hobbs C.V., et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;78:536&#x2013;547. doi: 10.1001/jamaneurol.2021.0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0504</ArticleId><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607&#x2013;1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem Inflammatory Syndrome in U. S. Children and Adolescents. N. Engl. J. Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., Bonanomi E., D&#x2019;Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771&#x2013;1778. doi: 10.1016/S0140-6736(20)31103-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., et al. Multisystem Inflammatory Syndrome in Children in New York State. N. Engl. J. Med. 2020;383:347&#x2013;358. doi: 10.1056/NEJMoa2021756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC, Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). 2020: CDC Health Alert Network.  [(accessed on 3 November 2023)]; Available online:  https://emergency.cdc.gov/han/2020/han00431.asp.</Citation></Reference><Reference><Citation>Godfred-Cato S., Bryant B., Leung J., Oster M.E., Conklin L., Abrams J., Roguski K., Wallace B., Prezzato E., Koumans E.H., et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children&#x2014;United States, March&#x2013;July 2020. MMWR Morb. Mortal Wkly. Rep. 2020;69:1074&#x2013;1080. doi: 10.15585/mmwr.mm6932e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6932e2</ArticleId><ArticleId IdType="pmc">PMC7440126</ArticleId><ArticleId IdType="pubmed">32790663</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams J.Y., Godfred-Cato S.E., Oster M.E., Chow E.J., Koumans E.H., Bryant B., Leung J.W., Belay E.D. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review. J. Pediatr. 2020;226:45&#x2013;54.e1. doi: 10.1016/j.jpeds.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7403869</ArticleId><ArticleId IdType="pubmed">32768466</ArticleId></ArticleIdList></Reference><Reference><Citation>Dionne A., Son M.B.F., Randolph A.G. An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Pediatr. Infect. Dis. J. 2022;41:e6&#x2013;e9. doi: 10.1097/INF.0000000000003393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003393</ArticleId><ArticleId IdType="pmc">PMC8658063</ArticleId><ArticleId IdType="pubmed">34889873</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay E.D., Abrams J., Oster M.E., Giovanni J., Pierce T., Meng L., Prezzato E., Balachandran N., Openshaw J.J., Rosen H.E., et al. Trends in Geographic and Temporal Distribution of US Children with Multisystem Inflammatory Syndrome during the COVID-19 Pandemic. JAMA Pediatr. 2021;175:837&#x2013;845. doi: 10.1001/jamapediatrics.2021.0630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.0630</ArticleId><ArticleId IdType="pmc">PMC8025123</ArticleId><ArticleId IdType="pubmed">33821923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley M., Goodman M., Madani R., Jaggi P., Keesari R., Zhang Q., Oster M.E. Cardiac complications in children with acute COVID-19 vs multisystem inflammatory syndrome in children (MIS-C) Am. Heart J. 2023;263:177&#x2013;182. doi: 10.1016/j.ahj.2023.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2023.05.012</ArticleId><ArticleId IdType="pmc">PMC10198793</ArticleId><ArticleId IdType="pubmed">37217158</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsaied T., Tremoulet A.H., Burns J.C., Saidi A., Dionne A., Lang S.M., Newburger J.W., de Ferranti S., Friedman K.G. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021;143:78&#x2013;88. doi: 10.1161/CIRCULATIONAHA.120.049836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049836</ArticleId><ArticleId IdType="pubmed">33166178</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams J.Y., Oster M.E., Godfred-Cato S.E., Bryant B., Datta S.D., Campbell A.P., Leung J.W., Tsang C.A., Pierce T.J., Kennedy J.L., et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: A retrospective surveillance study. Lancet Child Adolesc. Health. 2021;5:323&#x2013;331. doi: 10.1016/S2352-4642(21)00050-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00050-X</ArticleId><ArticleId IdType="pmc">PMC7943393</ArticleId><ArticleId IdType="pubmed">33711293</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M.B.F., Murray N., Friedman K., Young C.C., Newhams M.M., Feldstein L.R., Loftis L.L., Tarquinio K.M., Singh A.R., Heidemann S.M., et al. Multisystem Inflammatory Syndrome in Children&#x2014;Initial Therapy and Outcomes. N. Engl. J. Med. 2021;385:23&#x2013;34. doi: 10.1056/NEJMoa2102605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2102605</ArticleId><ArticleId IdType="pmc">PMC8220972</ArticleId><ArticleId IdType="pubmed">34133855</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Tenforde M.W., Friedman K.G., Newhams M., Rose E.B., Dapul H., Soma V.L., Maddux A.B., Mourani P.M., Bowens C., et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA. 2021;325:1074&#x2013;1087. doi: 10.1001/jama.2021.2091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2091</ArticleId><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltman J., Keesari R., Madani R., Jaggi P., Oster M.E. Six-month cardiac outcomes in children with multisystem inflammatory syndrome in children. Cardiol. Young. 2023;33:2632&#x2013;2638. doi: 10.1017/S1047951123000793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951123000793</ArticleId><ArticleId IdType="pubmed">37114296</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel T., Kelleman M., West Z., Peter A., Dove M., Butto A., Oster M.E. Comparison of Multisystem Inflammatory Syndrome in Children-Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine-Related Myocarditis in Children. J. Am. Heart. Assoc. 2022;11:e024393. doi: 10.1161/JAHA.121.024393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.024393</ArticleId><ArticleId IdType="pmc">PMC9238597</ArticleId><ArticleId IdType="pubmed">35475362</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddux A.B., Young C.C., Kucukak S., Zambrano L.D., Newhams M.M., Rollins C.K., Halasa N.B., Gertz S.J., Mack E.H., Schwartz S., et al. Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C. Front. Pediatr. 2023;11:1260372. doi: 10.3389/fped.2023.1260372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1260372</ArticleId><ArticleId IdType="pmc">PMC10619659</ArticleId><ArticleId IdType="pubmed">37920792</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfred-Cato S., Abrams J.Y., Balachandran N., Jaggi P., Jones K., Rostad C.A., Lu A.T., Fan L., Jabbar A., Anderson E.J., et al. Distinguishing Multisystem Inflammatory Syndrome in Children from COVID-19, Kawasaki Disease and Toxic Shock Syndrome. Pediatr. Infect. Dis. J. 2022;41:315&#x2013;323. doi: 10.1097/INF.0000000000003449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003449</ArticleId><ArticleId IdType="pmc">PMC8919949</ArticleId><ArticleId IdType="pubmed">35093995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels P.A., Bingler M.A. A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children. Prog. Pediatr. Cardiol. 2022;65:101516. doi: 10.1016/j.ppedcard.2022.101516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ppedcard.2022.101516</ArticleId><ArticleId IdType="pmc">PMC8925196</ArticleId><ArticleId IdType="pubmed">35313700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan L.K., Bai S., Du C., Bass M., Jones K., Sherry W., Morris C.R., Oster M.E., Shane A.L., Jaggi P. Distinguishing Incomplete Kawasaki and Nonsevere Multisystem Inflammatory Syndrome in Children. Hosp. Pediatr. 2023;13:e280&#x2013;e284. doi: 10.1542/hpeds.2022-007107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/hpeds.2022-007107</ArticleId><ArticleId IdType="pubmed">37681271</ArticleId></ArticleIdList></Reference><Reference><Citation>Melgar M., Lee E.H., Miller A.D., Lim S., Brown C.M., Yousaf A.R., Zambrano L.D., Belay E.D., Godfred-Cato S., Abrams J.Y., et al. Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection&#x2014;United States. MMWR Recomm. Rep. 2022;71:1&#x2013;14. doi: 10.15585/mmwr.rr7104a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.rr7104a1</ArticleId><ArticleId IdType="pmc">PMC9762894</ArticleId><ArticleId IdType="pubmed">36520808</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH  COVID-19 Treatment Guidelines Panel: Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.  [(accessed on 13 November 2023)];2023  Available online:  https://www.covid19treatmentguidelines.nih.gov/</Citation></Reference><Reference><Citation>Channon-Wells S., Vito O., McArdle A.J., Seaby E.G., Patel H., Shah P., Pazukhina E., Wilson C., Broderick C., D&#x2019;Souza G., et al. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: A propensity-weighted cohort study. Lancet Rheumatol. 2023;5:e184&#x2013;e199. doi: 10.1016/S2665-9913(23)00029-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(23)00029-2</ArticleId><ArticleId IdType="pmc">PMC9949883</ArticleId><ArticleId IdType="pubmed">36855438</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.B., Abrams J.Y., Godfred-Cato S., Kunkel A., Hammett T.A., Perez M.A., Hsiao H.M., Baida N., Rostad C.A., Ballan W., et al. Treatments and Severe Outcomes for Patients Diagnosed with MIS-C at Four Children&#x2019;s Hospitals in the United States, March 16, 2020-March 10, 2021. Pediatr. Infect. Dis. J. 2023;42:990&#x2013;998. doi: 10.1097/INF.0000000000004065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004065</ArticleId><ArticleId IdType="pmc">PMC11318085</ArticleId><ArticleId IdType="pubmed">37862698</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne A.B., Gilani Z., Godfred-Cato S., Belay E.D., Feldstein L.R., Patel M.M., Randolph A.G., Newhams M., Thomas D., Magleby R., et al. Incidence of Multisystem Inflammatory Syndrome in Children among US Persons Infected with SARS-CoV-2. JAMA Netw. Open. 2021;4:e2116420. doi: 10.1001/jamanetworkopen.2021.16420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16420</ArticleId><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.M., Carter M.J., Cheung C.R., Ladhani S. Lower Risk of Multisystem Inflammatory Syndrome in Children with the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2. Clin. Infect. Dis. 2023;76:e518&#x2013;e521. doi: 10.1093/cid/ciac553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac553</ArticleId><ArticleId IdType="pmc">PMC9278259</ArticleId><ArticleId IdType="pubmed">35788276</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.D., Yousaf A.R., Bornstein E., Wu M.J., Lindsey K., Melgar M., Oster M.E., Zambrano L.D., Campbell A.P. Multisystem Inflammatory Syndrome in Children during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta and Omicron Variant Circulation-United States, July 2021&#x2013;January 2022. Clin. Infect. Dis. 2022;75((Suppl. S2)):S303&#x2013;S307. doi: 10.1093/cid/ciac471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac471</ArticleId><ArticleId IdType="pmc">PMC9214171</ArticleId><ArticleId IdType="pubmed">35684958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf A.R., Miller A.D., Lindsey K., Shah A.B., Wu M.J., Melgar M., Zambrano L.D., Campbell A.P. Multisystem Inflammatory Syndrome in Children among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared with Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance. Pediatr. Infect. Dis. J. 2023;42:e476&#x2013;e478. doi: 10.1097/INF.0000000000004103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004103</ArticleId><ArticleId IdType="pmc">PMC11262462</ArticleId><ArticleId IdType="pubmed">37725819</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Long COVID or Post-COVID Conditions. 2023.  [(accessed on 13 November 2023)];2023 July 20; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>WHO  A clinical Case Definition for Post COVID-19 Condition in Children and Adolescents by Expert Consensus, 16 February 2023. 2023.  [(accessed on 13 November 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022;176:1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjaye-Gbewonyo D., Vahratian A., Perrine C.G., Bertolli J. Long COVID in Adults: United States, 2022. NCHS Data Brief; Hyattsville, MD, USA: 2023. pp. 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">37756137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill E.L., Mehta H.B., Sharma S., Mane K., Singh S.K., Xie C., Cathey E., Loomba J., Russell S., Spratt H., et al. Risk factors associated with post-acute sequelae of SARS-CoV-2: An N3C and NIH RECOVER study. BMC Public Health. 2023;23:2103. doi: 10.1186/s12889-023-16916-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-16916-w</ArticleId><ArticleId IdType="pmc">PMC10601201</ArticleId><ArticleId IdType="pubmed">37880596</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A., Janda A., Renk H., Stich M., Frieh P., Kaier K., Lohrmann F., Nieters A., Willems A., Huzly D., et al. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. EBioMedicine. 2022;84:104245. doi: 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R., Mariani F., Mastrantoni L., De Rose C., Zampino G., Munblit D., Sigfrid L., Valentini P., Buonsenso D. Risk factors for post-COVID-19 condition (Long Covid) in children: A prospective cohort study. EClinicalMedicine. 2023;59:101961. doi: 10.1016/j.eclinm.2023.101961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf A.R., Mak J., Gwynn L., Bloodworth R., Rai R., Jeddy Z., LeClair L.B., Edwards L., Olsho L.E.W., Newes-Adeyi G., et al. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021&#x2013;September 2022. Open Forum Infect. Dis. 2023;10((Suppl. S2)):ofad500.2466. doi: 10.1093/ofid/ofad500.2466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad500.2466</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb R.L., Vaca C.E., Paredes R., Mera J., Webb B.J., Perez G., Oguchi G., Ryan P., Nielsen B.U., Brown M., et al. Early Remdesivir to Prevent Progression to Severe COVID-19 in Outpatients. N. Engl. J. Med. 2022;386:305&#x2013;315. doi: 10.1056/NEJMoa2116846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116846</ArticleId><ArticleId IdType="pmc">PMC8757570</ArticleId><ArticleId IdType="pubmed">34937145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J., Leister-Tebbe H., Gardner A., Abreu P., Bao W., Wisemandle W., Baniecki M., Hendrick V.M., Damle B., Sim&#xf3;n-Campos A., et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with COVID-19. N. Engl. J. Med. 2022;386:1397&#x2013;1408. doi: 10.1056/NEJMoa2118542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Regan J.J., Moulia D.L., Link-Gelles R., Godfrey M., Mak J., Najdowski M., Rosenblum H.G., Shah M.M., Twentyman E., Meyer S., et al. Use of Updated COVID-19 Vaccines 2023&#x2013;2024 Formula for Persons Aged &#x2265;6 Months: Recommendations of the Advisory Committee on Immunization Practices&#x2014;United States, September 2023. MMWR Morb. Mortal Wkly. Rep. 2023;72:1140&#x2013;1146. doi: 10.15585/mmwr.mm7242e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7242e1</ArticleId><ArticleId IdType="pmc">PMC10602621</ArticleId><ArticleId IdType="pubmed">37856366</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Overview of COVID-19 Vaccines.  [(accessed on 23 November 2023)];2023  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-COVID-19-vaccines.html.</Citation></Reference><Reference><Citation>Barouch D.H. COVID-19 Vaccines&#x2013;Immunity, Variants, Boosters. N. Engl. J. Med. 2022;387:1011&#x2013;1020. doi: 10.1056/NEJMra2206573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2206573</ArticleId><ArticleId IdType="pmc">PMC9454645</ArticleId><ArticleId IdType="pubmed">36044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W., Huo J., Zhou D., Zahradn&#xed;k J., Supasa P., Liu C., Duyvesteyn H.M.E., Ginn H.M., Mentzer A.J., Tuekprakhon A., et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185:467&#x2013;484.e15. doi: 10.1016/j.cell.2021.12.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.12.046</ArticleId><ArticleId IdType="pmc">PMC8723827</ArticleId><ArticleId IdType="pubmed">35081335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers B.L., Chakraborty S., Xue Y., Gelbart T., Gonzalez J.C., Cassidy A.G., Golan Y., Prahl M., Gaw S.L., Arunachalam P.S., et al. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Sci. Transl. Med. 2022;14:eabn7842. doi: 10.1126/scitranslmed.abn7842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn7842</ArticleId><ArticleId IdType="pmc">PMC8891085</ArticleId><ArticleId IdType="pubmed">35025672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassauni&#xe8;re R., Polacek C., Frische A., Boding L., S&#xe6;kmose S.G., Rasmussen M., Fomsgaard A. Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine. JAMA Netw. Open. 2022;5:e2212073. doi: 10.1001/jamanetworkopen.2022.12073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.12073</ArticleId><ArticleId IdType="pmc">PMC9107029</ArticleId><ArticleId IdType="pubmed">35560054</ArticleId></ArticleIdList></Reference><Reference><Citation>Belongia E.A., Petrie J.G., Feldstein L.R., Guan L., Halfmann P.J., King J.P., Neumann G., Pattinson D., Rolfes M.A., McLean H.Q., et al. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection. J. Pediatr. Infect. Dis. Soc. 2023. ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piad109</ArticleId><ArticleId IdType="pubmed">38142128</ArticleId></ArticleIdList></Reference><Reference><Citation>Price A.M., Olson S.M., Newhams M.M., Halasa N.B., Boom J.A., Sahni L.C., Pannaraj P.S., Irby K., Bline K.E., Maddux A.B., et al. Overcoming Covid-19 Investigators. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N. Engl. J. Med. 2022;386:1899&#x2013;1909. doi: 10.1056/NEJMoa2202826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202826</ArticleId><ArticleId IdType="pmc">PMC9006785</ArticleId><ArticleId IdType="pubmed">35353976</ArticleId></ArticleIdList></Reference><Reference><Citation>Link-Gelles R., Ciesla A.A., Rowley E.A.K., Klein N.P., Naleway A.L., Payne A.B., Kharbanda A., Natarajan K., DeSilva M.B., Dascomb K., et al. Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters among Children Aged 6 Months-5 Years&#x2014;VISION Network, United States, July 2022&#x2013;June 2023. MMWR Morb. Mortal Wkly. Rep. 2023;72:886&#x2013;892. doi: 10.15585/mmwr.mm7233a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7233a2</ArticleId><ArticleId IdType="pmc">PMC10441825</ArticleId><ArticleId IdType="pubmed">37590187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray G., Collie S., Goga A., Garrett N., Champion J., Seocharan I., Bamford L., Moultrie H., Bekker L.G. Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa. N. Engl. J. Med. 2022;386:2243&#x2013;2245. doi: 10.1056/NEJMc2202061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2202061</ArticleId><ArticleId IdType="pmc">PMC9093716</ArticleId><ArticleId IdType="pubmed">35507482</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton A., Embi P.J., Levy M.E., Gaglani M., DeSilva M.B., Dixon B.E., Dascomb K., Patel P., Schrader K.E., Klein N.P., et al. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations among Immunocompromised Adults during SARS-CoV-2 Omicron Predominance&#x2014;VISION Network, 10 States, December 2021&#x2013;August 2022. MMWR Morb. Mortal Wkly. Rep. 2022;71:1335&#x2013;1342. doi: 10.15585/mmwr.mm7142a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7142a4</ArticleId><ArticleId IdType="pmc">PMC9590295</ArticleId><ArticleId IdType="pubmed">36264840</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCuir J., Surie D., Zhu Y., Gaglani M., Ginde A.A., Douin D.J., Talbot H.K., Casey J.D., Mohr N.M., McNeal T., et al. Effectiveness of Monovalent mRNACOVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation Death among Immunocompetent Adults during the Omicron Variant Period&#x2014;IVYNetwork 19, U.S. States, February 1, 2022&#x2013;January 31, 2023. MMWR Morb. Mortal Wkly. Rep. 2023;72:463&#x2013;468. doi: 10.15585/mmwr.mm7217a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7217a3</ArticleId><ArticleId IdType="pubmed">37104244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano L.D., Newhams M.M., Simeone R.M., Fleming-Dutra K.E., Halasa N., Wu M., Orzel-Lockwood A.O., Kamidani S., Pannaraj P.S., Chiotos K. Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network. Pediatr. Infect. Dis. J. 2023. Epub ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004225</ArticleId><ArticleId IdType="pmc">PMC11261536</ArticleId><ArticleId IdType="pubmed">38145397</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulia D.L., Wallace M., Roper L.E., Godfrey M., Rosenblum H.G., Link-Gelles R., Britton A., Daley M.F., Meyer S., Fleming-Dutra K.E., et al. Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged &#x2265;6 Months&#x2014;United States, April 2023. MMWR Morb. Mortal Wkly. Rep. 2023;72:657&#x2013;662. doi: 10.15585/mmwr.mm7224a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7224a3</ArticleId><ArticleId IdType="pmc">PMC10328466</ArticleId><ArticleId IdType="pubmed">37319020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hause A.M., Zhang B., Yue X., Marquez P., Myers T.R., Parker C., Gee J., Su J., Shimabukuro T.T., Shay D.K. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US. JAMA Netw Open. 2022;5:e2222241. doi: 10.1001/jamanetworkopen.2022.22241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.22241</ArticleId><ArticleId IdType="pmc">PMC9287747</ArticleId><ArticleId IdType="pubmed">35838667</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddard K., Donahue J.G., Lewis N., Hanson K.E., Weintraub E.S., Fireman B., Klein N.P. Safety of COVID-19 mRNA Vaccination among Young Children in the Vaccine Safety Datalink. Pediatrics. 2023;152:e2023061894. doi: 10.1542/peds.2023-061894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-061894</ArticleId><ArticleId IdType="pmc">PMC10468817</ArticleId><ArticleId IdType="pubmed">37278199</ArticleId></ArticleIdList></Reference><Reference><Citation>Piechotta V., Siemens W., Thielemann I., Toews M., Koch J., Vygen-Bonnet S., Kothari K., Grummich K., Braun C., Kapp P., et al. Safety and effectiveness of vaccines against COVID-19 in children aged 5&#x2013;11 years: A systematic review and meta-analysis. Lancet Child Adolesc. Health. 2023;7:379&#x2013;391. doi: 10.1016/S2352-4642(23)00078-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(23)00078-0</ArticleId><ArticleId IdType="pmc">PMC10112865</ArticleId><ArticleId IdType="pubmed">37084750</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster M.E., Shay D.K., Su J.R., Gee J., Creech C.B., Broder K.R., Edwards K., Soslow J.H., Dendy J.M., Schlaudecker E., et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US from December 2020 to August 2021. JAMA. 2022;327:331&#x2013;340. doi: 10.1001/jama.2021.24110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24110</ArticleId><ArticleId IdType="pmc">PMC8790664</ArticleId><ArticleId IdType="pubmed">35076665</ArticleId></ArticleIdList></Reference><Reference><Citation>Block J.P., Boehmer T.K., Forrest C.B., Carton T.W., Lee G.M., Ajani U.A., Christakis D.A., Cowell L.G., Draper C., Ghildayal N., et al. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination&#x2014;PCORnet, United States, January 2021&#x2013;January 2022. MMWR Morb. Mortal Wkly. Rep. 2022;71:517&#x2013;523. doi: 10.15585/mmwr.mm7114e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7114e1</ArticleId><ArticleId IdType="pmc">PMC8989373</ArticleId><ArticleId IdType="pubmed">35389977</ArticleId></ArticleIdList></Reference><Reference><Citation>See I., Lale A., Marquez P., Streiff M.B., Wheeler A.P., Tepper N.K., Woo E.J., Broder K.R., Edwards K.M., Gallego R., et al. Case Series of Thrombosis with Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. Ann. Intern. Med. 2022;175:513&#x2013;522. doi: 10.7326/M21-4502.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-4502</ArticleId><ArticleId IdType="pmc">PMC8787833</ArticleId><ArticleId IdType="pubmed">35038274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>